JP2010513430A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010513430A5 JP2010513430A5 JP2009542179A JP2009542179A JP2010513430A5 JP 2010513430 A5 JP2010513430 A5 JP 2010513430A5 JP 2009542179 A JP2009542179 A JP 2009542179A JP 2009542179 A JP2009542179 A JP 2009542179A JP 2010513430 A5 JP2010513430 A5 JP 2010513430A5
- Authority
- JP
- Japan
- Prior art keywords
- kit
- pharmaceutically acceptable
- disease
- solvate
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000003839 salts Chemical class 0.000 claims 11
- 239000012453 solvate Substances 0.000 claims 11
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 claims 7
- 239000013066 combination product Substances 0.000 claims 6
- 229940127555 combination product Drugs 0.000 claims 6
- 208000027866 inflammatory disease Diseases 0.000 claims 5
- 201000001320 Atherosclerosis Diseases 0.000 claims 4
- XUKUURHRXDUEBC-KAYWLYCHSA-N Atorvastatin Chemical compound C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CC[C@@H](O)C[C@@H](O)CC(O)=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 XUKUURHRXDUEBC-KAYWLYCHSA-N 0.000 claims 4
- XUKUURHRXDUEBC-UHFFFAOYSA-N Atorvastatin Natural products C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CCC(O)CC(O)CC(O)=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 XUKUURHRXDUEBC-UHFFFAOYSA-N 0.000 claims 4
- 229960005370 atorvastatin Drugs 0.000 claims 4
- 208000029078 coronary artery disease Diseases 0.000 claims 4
- 229960000672 rosuvastatin Drugs 0.000 claims 4
- BPRHUIZQVSMCRT-VEUZHWNKSA-N rosuvastatin Chemical compound CC(C)C1=NC(N(C)S(C)(=O)=O)=NC(C=2C=CC(F)=CC=2)=C1\C=C\[C@@H](O)C[C@@H](O)CC(O)=O BPRHUIZQVSMCRT-VEUZHWNKSA-N 0.000 claims 4
- 208000024172 Cardiovascular disease Diseases 0.000 claims 3
- 208000006011 Stroke Diseases 0.000 claims 3
- 239000002671 adjuvant Substances 0.000 claims 3
- 239000003085 diluting agent Substances 0.000 claims 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 3
- 208000035475 disorder Diseases 0.000 claims 3
- 238000004519 manufacturing process Methods 0.000 claims 3
- 238000000034 method Methods 0.000 claims 3
- HIANJWSAHKJQTH-UHFFFAOYSA-N pemirolast Chemical compound CC1=CC=CN(C2=O)C1=NC=C2C=1N=NNN=1 HIANJWSAHKJQTH-UHFFFAOYSA-N 0.000 claims 3
- 229960004439 pemirolast Drugs 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 208000027418 Wounds and injury Diseases 0.000 claims 2
- 208000007474 aortic aneurysm Diseases 0.000 claims 2
- 238000002648 combination therapy Methods 0.000 claims 2
- 230000006378 damage Effects 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 208000019622 heart disease Diseases 0.000 claims 2
- 230000002757 inflammatory effect Effects 0.000 claims 2
- 208000014674 injury Diseases 0.000 claims 2
- 208000010125 myocardial infarction Diseases 0.000 claims 2
- 239000000047 product Substances 0.000 claims 2
- 208000004476 Acute Coronary Syndrome Diseases 0.000 claims 1
- 206010002383 Angina Pectoris Diseases 0.000 claims 1
- 200000000007 Arterial disease Diseases 0.000 claims 1
- 206010003210 Arteriosclerosis Diseases 0.000 claims 1
- 208000037260 Atherosclerotic Plaque Diseases 0.000 claims 1
- 206010008190 Cerebrovascular accident Diseases 0.000 claims 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims 1
- 206010009900 Colitis ulcerative Diseases 0.000 claims 1
- 208000011231 Crohn disease Diseases 0.000 claims 1
- 208000019695 Migraine disease Diseases 0.000 claims 1
- 208000030831 Peripheral arterial occlusive disease Diseases 0.000 claims 1
- 201000004681 Psoriasis Diseases 0.000 claims 1
- 208000032109 Transient ischaemic attack Diseases 0.000 claims 1
- 201000006704 Ulcerative Colitis Diseases 0.000 claims 1
- 208000006673 asthma Diseases 0.000 claims 1
- 208000026106 cerebrovascular disease Diseases 0.000 claims 1
- 238000011260 co-administration Methods 0.000 claims 1
- 208000028867 ischemia Diseases 0.000 claims 1
- 208000023589 ischemic disease Diseases 0.000 claims 1
- 150000002596 lactones Chemical class 0.000 claims 1
- 206010027599 migraine Diseases 0.000 claims 1
- 201000006417 multiple sclerosis Diseases 0.000 claims 1
- 238000009877 rendering Methods 0.000 claims 1
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 1
- 201000000596 systemic lupus erythematosus Diseases 0.000 claims 1
- 201000010875 transient cerebral ischemia Diseases 0.000 claims 1
- 208000019553 vascular disease Diseases 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US87537706P | 2006-12-18 | 2006-12-18 | |
| US74307P | 2007-10-29 | 2007-10-29 | |
| PCT/GB2007/004408 WO2008074975A1 (en) | 2006-12-18 | 2007-11-16 | New combination for use in the treatment of inflammatory disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010513430A JP2010513430A (ja) | 2010-04-30 |
| JP2010513430A5 true JP2010513430A5 (cg-RX-API-DMAC7.html) | 2011-01-06 |
Family
ID=39135213
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009542179A Pending JP2010513430A (ja) | 2006-12-18 | 2007-11-16 | 炎症障害の治療において使用するための新たな併用 |
Country Status (20)
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UY32711A (es) | 2009-06-16 | 2011-01-31 | Cardoz Ab | Nueva forma cristalina de pemirolast |
| CA2780382A1 (en) * | 2009-11-13 | 2011-05-19 | Cardoz Ab | Pemirolast for the treatment of systemic low grade inflammation |
| CN102302780B (zh) * | 2011-09-01 | 2013-05-01 | 刘树芹 | 一种治疗支气管哮喘的药物组合物 |
| CN102389418A (zh) * | 2011-09-01 | 2012-03-28 | 刘树芹 | 一种含扎鲁司特和他汀类药物的药物组合物 |
| CN102274515B (zh) * | 2011-09-01 | 2013-04-24 | 刘树芹 | 一种含孟鲁司特和他汀类药物的药物组合物 |
| CA3087344A1 (en) | 2018-01-05 | 2019-07-11 | Platelet Biogenesis, Inc. | Compositions and methods for producing megakaryocytes |
| JP2021529770A (ja) * | 2018-06-29 | 2021-11-04 | プレートレット バイオジェネシス, インコーポレイテッド | 薬物送達のための組成物およびその使用方法 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4122274A (en) * | 1977-05-25 | 1978-10-24 | Bristol-Myers Company | 3-Tetrazolo-5,6,7,8-substituted-pyrido[1,2-a]pyrimidin-4-ones |
| JP2504788B2 (ja) * | 1987-11-10 | 1996-06-05 | 東京田辺製薬株式会社 | 9−メチル−3−(1H−テトラゾ―ル−5−イル)−4H−ピリド[1,2−a]ピリミジン−4−オンカリウム塩の水性製剤 |
| WO1995032714A1 (en) * | 1994-05-31 | 1995-12-07 | Tokyo Tanabe Company Limited | Arteriosclerosis depressant |
| WO1997045105A1 (en) * | 1996-05-24 | 1997-12-04 | Angiotech Pharmaceuticals, Inc. | Compositions and methods for treating or preventing diseases of body passageways |
| US7115278B2 (en) * | 1998-04-08 | 2006-10-03 | Theoharis C Theoharides | Proteoglycan compositions for the treatment of cardiovascular inflammatory diseases |
| US6232297B1 (en) * | 1999-02-01 | 2001-05-15 | University Of Virginia Patent Foundation | Methods and compositions for treating inflammatory response |
| US20030235595A1 (en) * | 1999-06-30 | 2003-12-25 | Feng-Jing Chen | Oil-containing, orally administrable pharmaceutical composition for improved delivery of a therapeutic agent |
| JP2003509478A (ja) * | 1999-09-21 | 2003-03-11 | エモリー・ユニバーシティ | 血小板関連障害を処置する方法および組成物 |
| US6379684B1 (en) * | 2001-05-02 | 2002-04-30 | Alphamed Pharaceutical Corp. | Cosmetic compositions containing cromolyn compounds for revitalizing the skin |
| ITMI20011764A1 (it) * | 2001-08-10 | 2003-02-10 | Dinamite Dipharma Spa | Metodo per l'ottenimento del pemirolast ad elevata purezza |
| JPWO2004002530A1 (ja) * | 2002-06-26 | 2005-10-27 | 小野薬品工業株式会社 | 慢性疾患治療剤 |
| JP4607436B2 (ja) * | 2002-08-02 | 2011-01-05 | 第一三共株式会社 | HMG−CoAリダクターゼ阻害剤を含有する医薬組成物 |
| JP4588986B2 (ja) * | 2002-08-20 | 2010-12-01 | テルモ株式会社 | 体内埋込医療器具 |
| EP1553075B1 (en) * | 2002-10-03 | 2013-08-14 | Ono Pharmaceutical Co., Ltd. | Lpa receptor antagonists |
| AU2004305154A1 (en) * | 2003-12-23 | 2005-07-07 | Medicure International Inc. | Combination therapies employing a composition comprising a HMG CoA reductase inhibitor and a vitamin B6 related compound |
| US8277831B2 (en) * | 2004-02-17 | 2012-10-02 | Advanced Technologies And Regenerative Medicine, Llc. | Drug-enhanced adhesion prevention |
| US20060084695A1 (en) * | 2004-04-29 | 2006-04-20 | John Griffin | Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase |
| US7803838B2 (en) * | 2004-06-04 | 2010-09-28 | Forest Laboratories Holdings Limited | Compositions comprising nebivolol |
| CA2593545A1 (en) * | 2005-01-06 | 2006-07-13 | Merck & Co., Inc. | Drug combination therapy and pharmaceutical compositions for treating inflammatory disorders |
| US7202325B2 (en) * | 2005-01-14 | 2007-04-10 | Advanced Cardiovascular Systems, Inc. | Poly(hydroxyalkanoate-co-ester amides) and agents for use with medical articles |
| NZ560386A (en) * | 2005-01-31 | 2009-12-24 | Mylan Lab Inc | Pharmaceutical composition comprising hydroxylated nebivolol |
| US20070225301A1 (en) * | 2006-02-13 | 2007-09-27 | Astion Inflammation Aps | Treatment of acne and other diseases |
| US8445437B2 (en) * | 2006-07-27 | 2013-05-21 | The Brigham And Women's Hospital, Inc. | Treatment and prevention of cardiovascular disease using mast cell stabilizers |
| CA2677493A1 (en) * | 2007-02-05 | 2008-08-14 | Xenon Pharmaceuticals Inc. | Pyridopyrimidinone compounds useful in treating sodium channel-mediated diseases or conditions |
-
2007
- 2007-11-16 EA EA200900815A patent/EA200900815A1/ru unknown
- 2007-11-16 KR KR1020097014879A patent/KR20090106526A/ko not_active Ceased
- 2007-11-16 ES ES07824625T patent/ES2394984T3/es active Active
- 2007-11-16 SI SI200731070T patent/SI2120919T1/sl unknown
- 2007-11-16 WO PCT/GB2007/004408 patent/WO2008074975A1/en not_active Ceased
- 2007-11-16 AU AU2007336118A patent/AU2007336118A1/en not_active Abandoned
- 2007-11-16 NZ NZ577467A patent/NZ577467A/en not_active IP Right Cessation
- 2007-11-16 HR HRP20120923TT patent/HRP20120923T1/hr unknown
- 2007-11-16 MX MX2009006507A patent/MX2009006507A/es active IP Right Grant
- 2007-11-16 PT PT07824625T patent/PT2120919E/pt unknown
- 2007-11-16 CA CA002672976A patent/CA2672976A1/en not_active Abandoned
- 2007-11-16 BR BRPI0720358-6A2A patent/BRPI0720358A2/pt not_active IP Right Cessation
- 2007-11-16 EP EP07824625A patent/EP2120919B1/en active Active
- 2007-11-16 CN CNA2007800514732A patent/CN101610765A/zh active Pending
- 2007-11-16 DK DK07824625.3T patent/DK2120919T3/da active
- 2007-11-16 JP JP2009542179A patent/JP2010513430A/ja active Pending
- 2007-12-16 US US12/448,326 patent/US20100063070A1/en not_active Abandoned
-
2009
- 2009-06-02 NO NO20092134A patent/NO20092134L/no not_active Application Discontinuation
- 2009-06-07 IL IL199214A patent/IL199214A/en not_active IP Right Cessation
-
2012
- 2012-11-27 CY CY20121101141T patent/CY1113636T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Aggarwal et al. | Cardiovascular safety of potential drugs for the treatment of coronavirus disease 2019 | |
| JP2022180461A5 (cg-RX-API-DMAC7.html) | ||
| Shen et al. | Effects of Lipo-Prostaglandin E1on Pulmonary Hemodynamics and Clinical Outcomes in Patients With Pulmonary Arterial Hypertension | |
| EP1961744A4 (en) | CONNECTION WITH BASIC GROUPS AND ITS USE | |
| JP2019048843A5 (cg-RX-API-DMAC7.html) | ||
| HRP20120923T1 (hr) | Nova kombinacija za upotrebu u lijeäśenju inflamatornih poremeä†aja | |
| HRP20170624T1 (hr) | Derivat piridina i pirazina za liječenje kronične opstrukcijske plućne bolesti | |
| JP2016172781A5 (cg-RX-API-DMAC7.html) | ||
| CN110036005A (zh) | 酰胺衍生物及其在药物中的应用 | |
| JP2016510326A5 (cg-RX-API-DMAC7.html) | ||
| JP2020193206A5 (cg-RX-API-DMAC7.html) | ||
| JP2014511891A5 (cg-RX-API-DMAC7.html) | ||
| JP2013537903A (ja) | カラノライド、その誘導体及び類似体についての医薬組成物並びにそれを製造するための方法 | |
| JP2015505565A5 (cg-RX-API-DMAC7.html) | ||
| FI3250182T3 (fi) | Dispergoituvia koostumuksia | |
| JP2023090869A5 (cg-RX-API-DMAC7.html) | ||
| AU2014249168A1 (en) | Methods of inhibiting leukotriene A4 hydrolase | |
| JP2020528888A5 (cg-RX-API-DMAC7.html) | ||
| PH12022550539A1 (en) | Therapeutic fusion proteins | |
| JP2017529830A5 (cg-RX-API-DMAC7.html) | ||
| JP2019535760A5 (ja) | ガボキサドールを用いた注意欠陥多動性障害(adhd)の治療方法 | |
| JP2015120685A5 (cg-RX-API-DMAC7.html) | ||
| JP2017533220A5 (cg-RX-API-DMAC7.html) | ||
| WO2017182873A3 (en) | Peptide-oligourea foldamer compounds and methods of their use | |
| JP2021073257A5 (cg-RX-API-DMAC7.html) |